Current Radiopharmaceuticals

481 papers and 5.2k indexed citations i.

About

The 481 papers published in Current Radiopharmaceuticals in the last decades have received a total of 5.2k indexed citations. Papers published in Current Radiopharmaceuticals usually cover Radiology, Nuclear Medicine and Imaging (337 papers), Pulmonary and Respiratory Medicine (116 papers) and Oncology (70 papers) specifically the topics of Radiopharmaceutical Chemistry and Applications (244 papers), Medical Imaging Techniques and Applications (166 papers) and Chemical Reactions and Isotopes (44 papers). The most active scholars publishing in Current Radiopharmaceuticals are Frank Roesch, Michael R. Zalutsky, Frank Bruchertseifer, Christos Apostolidis, D. Scott Wilbur, Marek Pruszyński, Ganesan Vaidyanathan, Ashutosh Dash, Michael R. McDevitt and David A. Scheinberg.

In The Last Decade

Fields of papers published in Current Radiopharmaceuticals

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in Current Radiopharmaceuticals. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in Current Radiopharmaceuticals

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in Current Radiopharmaceuticals. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in Current Radiopharmaceuticals with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025